New heart valve mimics nature to improve blood flow in major trial
Disease control
Recruiting now
This study compares a new heart valve, the DurAVR®, to standard TAVR valves in up to 1650 people with severe aortic stenosis. The valve is designed to mimic natural blood flow. Participants are randomly assigned to get the new valve or a standard one and are followed for up to 10…
Phase: NA • Sponsor: Anteris Technologies Ltd. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC